Skip to main content

Clinical TrialsSearch 1M+ trials from global registries Drug IntelligenceFollow pipelines from discovery to approval

Global ApprovalsTrack regulatory decisions across 12+ agencies

US FDA Drugs EU EMA Drugs Singapore HSA Drugs China NMPA Drugs Australia TGA Drugs Canada HC Drugs Spain CIMA-AEMPS Drugs UK EMC Drugs Saudi SFDA Drugs Malaysia NPRA Drugs Philippines FDA Drugs Kenya PPB Drugs

AI-Powered ResearchDiscover powerful insights with advanced AI analysis tools for clinical trials.Learn more →Premium AccessGet unlimited access to our comprehensive pharmaceutical database and analytics.Subscribe →

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

全欣达 - NMPA Drug Approval Details

Approvals/NMPA/Ofatumumab Injection

Approved

生物制品

Ofatumumab Injection

NOVARTIS PHARMACEUTICALS CORPORATION🇨🇳 National Medical Products Administration

Approval Date: Dec 20, 2021
Approval ID: 8CYo6QxPmqk
Company: NOVARTIS PHARMACEUTICALS CORPORATION
Type: 生物制品

Approval Details

Approval Id: 8CYo6QxPmqk
Approval Number: 国药准字SJ20210034
Generic Name: 奥法妥木单抗注射液
Generic Name En: Ofatumumab Injection
Trade Name: 全欣达
Drug Type: 生物制品
Dosage Form: 注射剂
Strength: 20mg（0.4mL）/支
Reg Date: 2021-12-20
Expired Date: 2026-12-19
Company Name: NOVARTIS PHARMACEUTICALS CORPORATION
Production Company Name: Novartis Pharma Stein AG
Company Detail Path: /organization/52bac6167dfe01f1/novartis-pharmaceuticals-corporation
Production Company Detail Path: /organization/9a7c301a6727a5d3/novartis-pharma-stein-ag

Approved

Quick Info

Agency

NMPA

Country

🇨🇳

Approval Date

Dec 20, 2021

Approval ID

8CYo6QxPmqk

Type

生物制品

Back to NMPA Approvals